PECAM1 and cerebral infarction: Next, immunofluorescence staining using CD31 (Lertkiatmongkol et al., 2016) showed that DA-treated mice had increased vascular area and length in the peri-infarct cortex compared with the control group, and DA alleviated the degree of vascular injury around the cerebral infarction.